Record revenue and profit growth were achieved, driven by strong KFC performance in Australia and Europe, disciplined cost control, and strategic exits. FY 2027 will focus on new restaurant openings, innovation, and operational excellence, with continued investment in growth and sustainability.Base…
Strong AI-driven demand is fueling rapid growth in the logic IC market, with ABF™ maintaining a dominant market share and expanding into next-generation technologies. Production capacity is being scaled up through major investments, while a collaborative, innovation-focused culture supports ongoing…
Revenue rose 3.8% to RMB24.4 billion, led by snack foods and emerging channels, but profit attributable to equity holders fell 11.5% due to higher costs and expenses. Gross margin declined to 46.3%, and the company increased capital expenditure and adjusted its dividend payout to retain cash for fu…
Record iX Suite and AI deal growth drove margin expansion and record Q2 cash flow, despite revenue headwinds from accelerated offshoring and client spending shifts. Guidance was lowered for revenue growth, but margin and free cash flow improvements are expected in the second half.Based on Concentri…
The meeting highlighted strong FY 2026 growth, improved operating leverage, and ongoing investment in AI and U.S. expansion. Board succession and executive incentives were key topics, with a special meeting planned to address share issuance limits. Shareholders engaged on profitability, cash flow…
Fiscal 2026 saw modest revenue growth, major product and technology launches, and strategic acquisitions, but also higher losses due to product mix and impairment. Expansion into Canada and new AI-driven platforms position the company for future growth amid strong industry tailwinds.Based on PetViv…
Record iX Suite growth and strong AI adoption drove margin expansion and record Q2 cash flow, despite revenue headwinds from accelerated offshoring and client spend reallocation. Full-year guidance was lowered, but margin and free cash flow improvements are expected to continue.Based on Concentrix…
The neuro-oncology pipeline features TLX101-Tx in phase III trials and Pixclara imaging under FDA review, targeting significant unmet needs in glioblastoma. Early clinical data show strong safety and promising efficacy, with a theranostic approach enabling precise patient selection and monitoring…
Record FY 2026 results with nearly $2B revenue and $286M adjusted EBITDA, both above guidance, driven by strong demand for drones and counter-UAS. FY 2027 guidance targets 10% revenue growth, with investments in capacity and R&D, but free cash flow will be negative due to high CapEx.Based on AeroVi…
The meeting reviewed strong FY26 growth, with total income up 34% and EBITDAFI up 137%. Strategic focus included platform investment, AI initiatives, and US market expansion. FY27 guidance anticipates continued growth amid external uncertainties.Original document: Serko Ltd. [SKO] Slides Release —…
Record revenue and underlying profitability were achieved, with strong growth in KFC Australia and Europe, a strategic exit from Taco Bell, and a sharpened focus on sustainability and climate targets. Net debt was reduced, dividends increased, and new growth initiatives are underway in Germany and…
Record revenue and underlying profits were achieved, driven by strong KFC performance in Australia and Europe, digital growth, and operational improvements. The company reduced net debt, exited Taco Bell, and declared a higher dividend, while preparing for further expansion and innovation in FY27.O…
Record revenue and profit growth driven by strong KFC performance in Australia and Europe, with successful Taco Bell exit and strategic investments in new concepts and markets. FY27 will focus on accelerated growth, innovation, and disciplined capital allocation.Original document: Collins Foods Lim…
Significant deleveraging and restructuring led to improved margins and reduced debt, with core operations in bank object delivery and B2B logistics preserved. The exit from B2C logistics and asset sales are expected to further strengthen results in 2026.Original document: Sequoia Logistica e Transp…
Record Q4 and full-year revenue driven by strong SaaS and Elite SaaS growth, with Adjusted EBITDA margin exceeding guidance. Fiscal 2026 net profit declined due to restructuring costs, but recurring revenue base and SaaS momentum support positive FY27 outlook.Original document: TECSYS Inc. [TCS] Ea…
A new strategy reset focuses on customer reliability, targeted network growth, and cost transformation to restore profitability. FY26 loss guidance remains unchanged, with operational improvements and disciplined capital allocation underway. Further financial updates are expected at the annual resu…
A new strategy reset prioritizes profitability, customer experience, targeted network growth, and cost discipline, with $100 million in annualized savings expected from FY27. Further updates will be shared at the FY26 results and a November 2026 Investor Day.Original document: Air New Zealand Limit…
The cardiometabolic pipeline leverages RNAi technology to address both rare and prevalent lipid disorders, with REDEMPLO already launched and multiple late-stage programs advancing. Key upcoming milestones include pivotal data for plozasiran and zodasiran, and first human data for the dual-targetin…
Record FY26 results with $2B revenue, 31% Q4 organic growth, and $2.7B bookings. FY27 guidance targets 10% revenue growth, stable margins, and major CapEx for capacity expansion. Strong demand for drones, counter-UAS, and space/cyber solutions underpins multi-year growth.Based on AeroVironment, Inc…
The meeting covered director elections, auditor ratification, a reverse stock split, executive compensation, and equity plan amendments. All proposals were approved by stockholders, with final results to be filed with the SEC. Stockholders were invited to submit questions.Based on Kairos Pharma, Lt…
